中硼硅药用玻璃发展现状和趋势  

Development Status of Middle Borosilicate Pharmaceutical Glass

作　　者：蔡冬雪 匡波 毛露路 郝良振 马赫 CAI Dongxue;KUANG Bo;MAO Lulu;HAO Liangzhen;MA He(CDGM Co.,Ltd.,Chengdu 610100,China)

机构地区：[1]成都光明光电股份有限公司,成都610100

出　　处：《玻璃》2023年第1期20-29,共10页Glass

摘　　要：新冠疫苗包装对药用玻璃产生巨大需求,一定程度上改变了现有中硼硅玻璃市场格局。作为药物包装的最适玻璃材料,中硼硅玻璃也由此迎来了新一轮的发展。国外中硼硅玻璃生产商德国肖特、美国康宁、日本电气硝子公司加大药用玻璃投资力度,发展势头强劲;国内通过政策引领以及在配方优化、工艺突破、设备改进、标准编制等方面的持续提升,使得中硼硅玻璃产业有了一定的进步和发展,产品已经实现出口国外。受疫情影响,中硼硅玻璃在未来仍然会持续发展,国内大部分低硼硅药用玻璃也会逐渐被中硼硅玻璃所替代,进而实现中硼硅玻璃作为医药包装材料的全面普及。The huge demand of medicinal glasses from COVID-19 vaccine packaging has changed the market landscape of current middle borosilicate glass in some extent. As an excellent material for drug packaging, middle borosilicate glass ushered a new round of development. Foreign middle borosilicate manufacturers, such as Schott, Corning and Nippon Electric Glass, have increased their investment in pharmaceutical glasses and generate strong development momentum. In China, through the policy guidance, as well as the glass component optimization, technical breakthrough, equipment improvement,standard compilation and other aspects of continuous improvement, so that the middle borosilicate glass has a certain progress and development, and even has been exported to foreign countries. Affected by the COVID-19, middle borosilicate glass will continuously develop in the future, and most of the low borosilicate glass in China will be replaced by middle borosilicate glass gradually, then the comprehensive popularization of middle borosilicate glass as pharmaceutical packaging materials will be achieved.

关 键 词：玻璃工业 药用玻璃 中硼硅玻璃 线热膨胀系数 化学稳定性 

分 类 号：TQ171[化学工程—玻璃工业]